These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
667 related articles for article (PubMed ID: 20144135)
21. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans? Monro A Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076 [TBL] [Abstract][Full Text] [Related]
22. Carcinogenic and genotoxic potential of turf pesticides commonly used on golf courses. Knopper L; Lean DR J Toxicol Environ Health B Crit Rev; 2004; 7(4):267-79. PubMed ID: 15205044 [TBL] [Abstract][Full Text] [Related]
23. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
24. Comparison of carcinogenic and in vivo genotoxic potency estimates. Sanner T; Dybing E Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476 [TBL] [Abstract][Full Text] [Related]
25. The results of assays in Drosophila as indicators of exposure to carcinogens. Vogel EW; Graf U; Frei HJ; Nivard MM IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398 [TBL] [Abstract][Full Text] [Related]
26. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062 [TBL] [Abstract][Full Text] [Related]
27. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
28. An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approach. Halleck M; Davis HR; Kirschmeier P; Levitan D; Snyder RD; Treinen K; Macdonald JS Toxicology; 2009 Apr; 258(2-3):116-30. PubMed ID: 19428931 [TBL] [Abstract][Full Text] [Related]
29. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Kirkland DJ; Aardema M; Banduhn N; Carmichael P; Fautz R; Meunier JR; Pfuhler S Mutagenesis; 2007 May; 22(3):161-75. PubMed ID: 17369606 [TBL] [Abstract][Full Text] [Related]
30. Nongenotoxic (epigenetic) carcinogens: pesticides as an example. A critical review. Rakitsky VN; Koblyakov VA; Turusov VS Teratog Carcinog Mutagen; 2000; 20(4):229-40. PubMed ID: 10910473 [TBL] [Abstract][Full Text] [Related]
31. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539 [TBL] [Abstract][Full Text] [Related]
32. Background to the ADI/TDI/PTWI. Herrman JL; Younes M Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623 [TBL] [Abstract][Full Text] [Related]
33. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131 [TBL] [Abstract][Full Text] [Related]
34. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests. Kim BS; Margolin BH Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179 [TBL] [Abstract][Full Text] [Related]
35. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618 [TBL] [Abstract][Full Text] [Related]
36. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate. Hasegawa R; Koizumi M; Hirose A Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717 [TBL] [Abstract][Full Text] [Related]
37. INRS activities on risk assessment of glycol ethers. Fastier A; Herve-Bazin B; McGregor DB Toxicol Lett; 2005 Mar; 156(1):59-76. PubMed ID: 15705488 [TBL] [Abstract][Full Text] [Related]
38. The redundancy of mouse carcinogenicity bioassays. Schach von Wittenau M; Estes PC Fundam Appl Toxicol; 1983; 3(6):631-9. PubMed ID: 6662305 [TBL] [Abstract][Full Text] [Related]
39. A retrospective analysis of Acute Reference Doses for pesticides evaluated in the European Union. Solecki R; Moeller T; Herrmann M; Stein B Crit Rev Toxicol; 2010 Jan; 40(1):24-34. PubMed ID: 20144134 [TBL] [Abstract][Full Text] [Related]
40. The in vivo rodent test systems for assessment of carcinogenic potential. van der Laan JW; Spindler P Regul Toxicol Pharmacol; 2002 Feb; 35(1):122-5. PubMed ID: 11846641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]